Skip to main content
Equibles

BNP PARIBAS ARBITRAGE, SA

Position in LXEO — Lexeo Therapeutics, Inc.

CIK 1166588 NEW YORK, NY
Back to LXEO Full portfolio

Position in LXEO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,807,992
+$498,119 QoQ
Shares Held
388,398
+70.2% QoQ
Ownership
0.473%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 141 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in LXEO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BNP PARIBAS ARBITRAGE, SA holds $3,331,911,027 across 414 Biotechnology names. LXEO ranks #99 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MRNA
Moderna, Inc.
 4,377,120 $306,529,713
2 REGN
Regeneron Pharmaceuticals, Inc.
 399,847 $249,320,598
3 ARGX
Argenx SE
 157,958 $146,548,693
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 262,258 $130,271,416
5 BNTX
BioNTech SE
 1,319,517 $122,781,056
6 RVMD
Revolution Medicines, Inc.
 552,710 $103,511,528
7 ORKA
Oruka Therapeutics, Inc.
 1,079,015 $102,689,857
8 BBIO
BridgeBio Pharma, Inc.
 1,155,442 $86,057,320

All Filings in LXEO

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,807,992 388,398
2026-03-31 $1,309,873 228,201
2025-12-31 $2,556,150 257,417
2025-09-30 $204,027 30,727
2025-06-30 $194,704 48,434
2025-03-31 $139,532 40,211
2024-12-31 $227,187 34,527
2024-09-30 $50,090 5,541
2024-06-30 $31,278 1,950
2024-03-31 $74,966 4,781